13 results match your criteria: "Smita Memorial Hospital & Research Center[Affiliation]"
Front Cell Infect Microbiol
October 2024
Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
Introduction: There are multiple ongoing outbreaks of carbapenem resistant (CR) infection in Fiji's hospitals. CR is able to colonize and persist on various hospital surfaces for extended periods. We conducted a study to understand the extent of hospital environmental contamination and phylogenetic links with clinical isolates.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
June 2024
Iqraa Hospital, Calicut, India.
Adenoid hypertrophy (AH) and its sequel like nasal obstruction, obstructive sleep apnoea (OSA), recurrent rhinitis and middle ear disorders are common diseases of pediatric age group, forming the major bulk of pediatric outpatient visits. The recommended approach to treating OSA in children is through adenotonsillectomy. Adenoidectomy is the surgical procedure of removal of hypertrophied adenoid tissues, which is the most common surgery performed by Ear, Nose, and Throat (ENT) surgeons.
View Article and Find Full Text PDFLancet Reg Health West Pac
June 2024
Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
Background: Carbapenem resistant organisms (CROs) such as (CR), (CR), (CR), and (CR) have been identified by the World Health Organization (WHO) as global priority pathogens. The dissemination of these pathogens and clonal outbreaks within healthcare facilities are of serious concern, particularly in regions with limited resources. In Fiji, where healthcare services are primarily provided by public hospitals, understanding the extent and nature of this problem is essential for the development of effective patient management, prevention interventions and control strategies.
View Article and Find Full Text PDFCureus
March 2023
Surgery, Smita Memorial Hospital and Research Centre, Thodupuzha, IND.
Dirofilariasis is a zoonotic infection transmitted by several species of mosquitoes. A 16-year-old boy presented with forearm swelling of two months duration. Imaging studies revealed a parasitic cyst.
View Article and Find Full Text PDFSouth Asian J Cancer
April 2022
Smita Memorial Hospital & Research Center, Thodupuza, Kerala, India.
Br J Psychiatry
April 2017
Roberto Lewis-Fernández, MD, MTS, Department of Psychiatry, Columbia University and New York State Center of Excellence for Cultural Competence, Anxiety Disorders Clinic, and Hispanic Treatment Program, at the New York State Psychiatric Institute, New York, New York, USA; Neil Krishan Aggarwal, MD, MBA, MA, Department of Psychiatry, Columbia University and New York State Center of Excellence for Cultural Competence at the New York State Psychiatric Institute, New York, New York, USA; Peter C. Lam, MPH, New York State Center of Excellence for Cultural Competence at the New York State Psychiatric Institute, New York, New York, USA; Hanga Galfalvy, PhD, Departments of Psychiatry and Biostatistics, Columbia University and Division of Biostatistics, New York State Psychiatric Institute, New York, New York, USA; Mitchell G. Weiss, MD, PhD, Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute and University of Basel, Basel Switzerland; Laurence J. Kirmayer, MD, Division of Social & Transcultural Psychiatry, McGill University and Culture & Mental Health Research Unit, Institute of Community & Family Psychiatry, Jewish General Hospital, Montreal, Quebec, Canada; Vasudeo Paralikar, MBBS, MD, PhD, Psychiatry Unit, King Edward Memorial Hospital, Pune, India; Smita N. Deshpande, MD, DPM, Department of Psychiatry, Post-Graduate Institute of Medical Education and Research, Dr. Ram Manohar Lohia Hospital, New Delhi, India; Esperanza Díaz, MD, Department of Psychiatry, Yale University, New Haven, Connecticut, USA; Andel V. Nicasio, MSEd, New York State Center of Excellence for Cultural Competence at the New York State Psychiatric Institute, New York, New York, USA; Marit Boiler, MPH, New York State Center of Excellence for Cultural Competence at the New York State Psychiatric Institute, New York, New York, USA; Renato D. Alarcón, MD, MPH, Department of Psychiatry, Mayo Clinic College of Medicine, Rochester, Minnesota, USA and Universidad Peruana Cayetano Heredia, Lima, Peru; Hans Rohlof, MD, Centrum '45, Oegstgeest, the Netherlands; Simon Groen, MA, Department of Anthropology, University of Amsterdam, Amsterdam, The Netherlands and De Evenaar Centre for Transcultural Psychiatry, GGZ Drenthe Mental Health Care, Assen, The Netherlands; Rob C. J. van Dijk, MSc, Parnassia Psychiatric Institute, The Hague, The Netherlands; Sushrut Jadhav, MBBS, MD, MRCPsych, PhD, Division of Psychiatry, University College London, London, UK; Sanjeev Sarmukaddam, PhD, Department of Biostatistics, Maharashtra Institute of Mental Health, Sassoon Govt. Hospital Campus, Pune, India; David Ndetei, MBChB, DPM, MRCPsych, FRCPsych, MD, DSc, Department of Psychiatry, University of Nairobi and Africa Mental Health Foundation, Nairobi, Kenya; Monica Z. Scalco, MD, PhD, Department of Psychiatry, University of Toronto and Toronto Western Hospital, Toronto, Ontario, Canada; Kavoos Bassiri, MS, LMFT, LPCC, CGP, Richmond Area Multi-Services Inc. and Department of Psychiatry, University of California, San Francisco, San Francisco, California, USA; Sergio Aguilar-Gaxiola, MD, PhD, Department of Internal Medicine and Center for Reducing Health Disparities, University of California, Davis, Sacramento, California, USA; Hendry Ton, MD, MS, Department of Psychiatry and Behavioral Sciences and Center for Reducing Health Disparities, University of California, Davis and Asian Pacific Community Counseling-Transcultural Wellness Center, Sacramento, California, USA; Joseph Westermeyer, MD, PhD, Department of Psychiatry, University of Minnesota and Minneapolis VA Medical Center, Minneapolis, Minnesota, USA; Johann M. Vega-Dienstmaier, MD, Department of Psychiatry, Universidad Peruana Cayetano Heredia and Hospital Nacional Cayetano Heredia, Lima, Peru.
There is a need for clinical tools to identify cultural issues in diagnostic assessment.To assess the feasibility, acceptability and clinical utility of the DSM-5 Cultural Formulation Interview (CFI) in routine clinical practice.Mixed-methods evaluation of field trial data from six countries.
View Article and Find Full Text PDFJ Clin Oncol
May 2017
Christopher J. Gibson, R. Coleman Lindsley, Brenton G. Mar, Jiantao Shi, Ann S. Lacasce, Arnold S. Freedman, David C. Fisher, Eric Jacobsen, Philippe Armand, Edwin P. Alyea, John Koreth, Vincent Ho, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz, Sarah Nikiforow, Franziska Michor, and Donna Neuberg, Dana-Farber Cancer Institute; Jiantao Shi and Franziska Michor, Harvard T.H. Chan School of Public Health; Siddhartha Jaiswal, Elizabeth A. Morgan, and Benjamin L. Ebert, Brigham and Women's Hospital, Boston; Benjamin L. Ebert, Broad Institute, Cambridge, MA; Vatche Tchekmedyian, Memorial Sloan Kettering Cancer Center, New York, NY; Alysia Bosworth, Anita Bansal, and Stephen J. Forman, City of Hope National Medical Center, Duarte, CA; and Liton Francisco, Jianbo He, Ravi Bhatia, and Smita Bhatia, University of Alabama at Birmingham, Birmingham, AL.
Purpose Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition characterized by somatic mutations in the blood of otherwise healthy adults. We hypothesized that in patients undergoing autologous stem-cell transplantation (ASCT) for lymphoma, CHIP at the time of ASCT would be associated with an increased risk of myelodysplastic syndrome and acute myeloid leukemia, collectively termed therapy-related myeloid neoplasm (TMN), and other adverse outcomes. Methods We performed whole-exome sequencing on pre- and post-ASCT samples from 12 patients who developed TMN after autologous transplantation for Hodgkin lymphoma or non-Hodgkin lymphoma and targeted sequencing on cryopreserved aliquots of autologous stem-cell products from 401 patients who underwent ASCT for non-Hodgkin lymphoma between 2003 and 2010.
View Article and Find Full Text PDFJ Clin Oncol
October 2016
Wendy van Dorp and Sebastian J. Neggers, Erasmus University Medical Centre; Wendy van Dorp, Sophia Children's Hospital, Rotterdam; Renée L. Mulder and Leontien C.M. Kremer, Emma Children's Hospital and Academic Medical Centre; Marleen H. van den Berg, Eline van Dulmen-den Broeder, and Cornelis B. Lambalk, Vrije Universiteit Medical Center, Amsterdam; Marry M. van den Heuvel-Eibrink, Princess Maxima Center for Pediatric Oncology; Hanneke M. van Santen, Wilhelmina Children's Hospital, University Medical Center, Utrecht, the Netherlands; Melissa M. Hudson, St Jude Children's Research Hospital, Memphis, TN; Jennifer M. Levine, Columbia University Medical Center; Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center, New York; Louis S. Constine, University of Rochester Medical Center, Rochester, NY; Natascia di Iorgi, University of Genoa; Riccardo Haupt, Istituto Giannina Gaslini, Genoa; Andreas Corrias and Alesandro Mussa, University of Turin, Turin; Alberto Revelli, S. Anna Hospital and University of Torino, Torino, Italy; Assunta Albanese, St George's University Hospitals NHS Foundation Trust; Gill Levitt and Alison Leiper, Great Ormond St Hospital for Children NHS Foundation Trust, London; Roderick Skinner, Great North Children's Hospital and Newcastle University, Newcastle upon Tyne; Andrew Toogood, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham; William H. Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom; Saro H. Armenian, City of Hope, Duarte, CA; Smita Bhatia and Wendy Landier, University of Alabama at Birmingham, Birmingham, AL; Rebecca Deans, University of New South Wales, Sydney, New South Wales, Australia; Uta Dirksen, Westfalian Wilhelms University Muenster, University Hospital Muenster, Germany; Clarisa R. Gracia, University of Pennsylvania, Philadelphia, PA; Lars Hjorth, Skåne University Hospital and Lund University, Lund, Sweden; Leah Kroon, Seattle Children's Hospital, Seat
Purpose: Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were treated with alkylating agents and/or radiation, with potential exposure of the ovaries, have an increased risk of premature ovarian insufficiency (POI). Clinical practice guidelines can facilitate these survivors' access to optimal treatment of late effects that may improve health and quality of survival; however, surveillance recommendations vary among the existing long-term follow-up guidelines, which impedes the implementation of screening.
Patients And Methods: The present guideline was developed by using an evidence-based approach and summarizes harmonized POI surveillance recommendations for female survivors of CAYA cancer who were diagnosed at age < 25 years.
J Clin Oncol
March 2016
Xuexia Wang, University of Wisconsin-Milwaukee, Milwaukee, WI; Can-Lan Sun, Molly Mather, Saro H. Armenian, City of Hope, Duarte; Jerome I. Rotter, Kent D. Taylor, Yii-Der Ida Chen, Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles, Torrance, CA; Adolfo Quiñones-Lombraña, Javier G. Blanco, State University of New York at Buffalo, Buffalo; Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center, New York, NY; Purnima Singh, Wendy Landier, Lindsey Hageman, Smita Bhatia, University of Alabama at Birmingham, Birmingham, AL; Naomi Winick, University of Texas Southwestern Medical Center, Dallas; Zoann E. Dreyer, Texas Children's Cancer Center, Houston, TX; Jill P. Ginsberg, Childrens Hospital of Philadelphia, Philadelphia, PA; Joseph P. Neglia, University of Minnesota, Minneapolis, MN; Sharon M. Castellino, Emory University and Children's Healthcare of Atlanta, Atlanta, GA; and Melissa M. Hudson, Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN.
Purpose: Interindividual variability in the dose-dependent association between anthracyclines and cardiomyopathy suggests that genetic susceptibility could play a role. The current study uses an agnostic approach to identify genetic variants that could modify cardiomyopathy risk.
Methods: A genome-wide association study was conducted in childhood cancer survivors with and without cardiomyopathy (cases and controls, respectively).
J Clin Oncol
March 2016
Tara O. Henderson and Kenan Onel, University of Chicago, Chicago, IL; Chaya S. Moskowitz, Joanne F. Chou, Chau T. Dang, Danielle Novetsky Friedman, Dana Barnea, Elena Lorenzi, and Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center, New York, NY; Angela R. Bradbury, University of Pennsylvania, Philadelphia, PA; Joseph Phillip Neglia, University of Minnesota, Minneapolis, MN; Smita Bhatia, University of Alabama, Birmingham, AL; Louise C. Strong and Marilyn Stovall, MD Anderson Cancer Center, Houston, TX; Lisa B. Kenney and Lisa R. Diller, Dana-Farber Cancer Institute/Children's Hospital Boston, Boston, MA; Elena Lorenzi, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Sue Hammond, Nationwide Children's Hospital, Columbus, OH; Wendy M. Leisenring, Fred Hutchinson Cancer Research Center, Seattle, WA; and Leslie L. Robison and Gregory T. Armstrong, St Jude Children's Research Hospital, Memphis, TN.
Purpose: Little is known about the breast cancer risk among childhood cancer survivors who did not receive chest radiotherapy. We sought to determine the magnitude of risk and associated risk factors for breast cancer among these women.
Patients And Methods: We evaluated cumulative breast cancer risk in 3,768 female childhood cancer survivors without a history of chest radiotherapy who were participants in the Childhood Cancer Survivor Study.
J Clin Oncol
July 2014
Chaya S. Moskowitz, Joanne F. Chou, Suzanne L. Wolden, Jonine L. Bernstein, Danielle Novetsky Friedman, Nidha Z. Mubdi, Colin B. Begg, and Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center; Jyoti Malhotra, Mount Sinai Medical Center, New York, NY; Wendy M. Leisenring, Fred Hutchinson Cancer Research Center, Seattle, WA; Marilyn Stovall and Susan A. Smith, University of Texas MD Anderson Cancer Center, Houston, TX; Sue Hammond, Nationwide Children's Hospital, Columbus, OH; Tara O. Henderson, University of Chicago Medicine Comer Children's Hospital, Chicago, IL; John D. Boice, Vanderbilt-Ingram Cancer Center, Nashville; Melissa M. Hudson and Leslie L. Robison, St Jude Children's Research Hospital, Memphis, TN; Lisa R. Diller and Lisa B. Kenney, Dana-Farber Cancer Institute, Boston, MA; Smita Bhatia, City of Hope National Medical Center, Duarte, CA; and Joseph P. Neglia, University of Minnesota Masonic Cancer Center, Minneapolis, MN.
Purpose: The risk of breast cancer is high in women treated for a childhood cancer with chest irradiation. We sought to examine variations in risk resulting from irradiation field and radiation dose.
Patients And Methods: We evaluated cumulative breast cancer risk in 1,230 female childhood cancer survivors treated with chest irradiation who were participants in the CCSS (Childhood Cancer Survivor Study).
J Clin Oncol
March 2014
Xuexia Wang, University of Wisconsin-Milwaukee, Milwaukee, WI; Wei Liu and Yutaka Yasui, University of Alberta; Sunil Desai, Stollery Children's Hospital, Edmonton, AB, Canada; Can-Lan Sun, Saro H. Armenian, Lindsey Hageman, Yan Ding, Wendy Landier, and Smita Bhatia, City of Hope, Duarte; Lu Chen, University of Southern California, Los Angeles, CA; Hakon Hakonarson and Jill P. Ginsberg, Children's Hospital of Philadelphia, Philadelphia, PA; Javier G. Blanco, Alfo Quiñones, and Daniel Ferguson, The State University of New York at Buffalo, Buffalo; Charles A. Sklar, Memorial Sloan-Kettering Cancer Center, New York City; Irene Cherrick, Upstate Medical University, Syracuse, NY; Naomi Winick, University of Texas Southwestern Medical Center, Dallas; Zoann E. Dreyer, Baylor College of Medicine, Houston, TX; Frank Keller, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA; Joseph P. Neglia, University of Minnesota Medical School, Minneapolis, MN; Sharon M. Castellino, Wake Forest University Health Sciences, Winston-Salem, NC; and Melissa M. Hudson, Leslie L. Robison, and Mary V. Relling, St. Jude Children's Research Hospital, Memphis, TN.
Purpose: The strong dose-dependent association between anthracyclines and cardiomyopathy is further exacerbated by the co-occurrence of cardiovascular risk factors (diabetes and hypertension). The high morbidity associated with cardiomyopathy necessitates an understanding of the underlying pathogenesis so that targeted interventions can be developed.
Patients And Methods: By using a two-stage design, we investigated host susceptibility to anthracycline-related cardiomyopathy by using the ITMAT/Broad CARe cardiovascular single nucleotide polymorphism (SNP) array to profile common SNPs in 2,100 genes considered relevant to de novo cardiovascular disease.